21 Einträge gefunden

1. The Role of Allogeneic Stem Cell Transplantation in Relapsed/Refractory Hodgkin's Lymphoma Patients.

   1. Klyuchnikov, Evgeny
   2. Bacher, Ulrike
   3. Kröger, Nicolaus
   4. Kazantsev, Ilya
   5. Zabelina, Tatjana
   6. Ayuketang Ayuk, Francis
   7. Zander, Axel R.

   2011 - Forschungsinformationssystem des UKE
2. Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT.

   1. Alchalby, Haefaa
   2. Badbaran, Anita
   3. Bock, O
   4. Fehse, Boris
   5. Bacher, Ulrike
   6. Zander, Axel R.
   7. Kröger, Nicolaus

   2010 - Forschungsinformationssystem des UKE
3. Diagnostic tools in the indications for allogeneic stem cell transplantation in myelodysplastic syndromes.

   1. Bacher, Ulrike
   2. Haferlach, Claudia
   3. Kröger, Nicolaus
   4. Schnittger, Susanne
   5. Kern, Wolfgang
   6. Wiedemann, Bettina
   7. Zander, Axel R.

   2010 - Forschungsinformationssystem des UKE
4. HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen.

   1. Kröger, Nicolaus
   2. Zabelina, Tatjana
   3. Binder, Thomas
   4. Ayuketang Ayuk, Francis
   5. Bacher, Ulrike
   6. Amtsfeld, Gitta
   7. Lellek, Heinrich

   2009 - Forschungsinformationssystem des UKE
5. Safety of conditioning agents for allogeneic haematopoietic transplantation.

   1. Bacher, Ulrike
   2. Klyuchnikov, Evgeny
   3. Wiedemann, Bettina
   4. Kröger, Nicolaus
   5. Zander, Axel R.

   2009 - Forschungsinformationssystem des UKE
6. Current status and perspectives of tyrosine kinase inhibitor treatment in the post-transplant period in patients with chronic myeloid leukemia (CML).

   1. Klyuchnikov, Evgeny
   2. Kröger, Nicolaus
   3. Brümmendorf, Tim
   4. Wiedemann, Bettina
   5. Zander, Axel R.
   6. Bacher, Ulrike

   2009 - Forschungsinformationssystem des UKE
7. Bone marrow mesenchymal stromal cells remain of recipient origin after allogeneic SCT and do not harbor the JAK2V617F mutation in patients with myelofibrosis.

   1. Bacher, Ulrike
   2. Asenova, Svetlana
   3. Badbaran, Anita
   4. Zander, Axel R.
   5. Alchalby, Haefaa
   6. Fehse, Boris
   7. Kröger, Nicolaus

   2009 - Forschungsinformationssystem des UKE
8. Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib.

   1. Schafhausen, Philippe
   2. Dierlamm, Judith
   3. Bokemeyer, Carsten
   4. Brümmendorf, Tim
   5. Bacher, Ulrike
   6. Zander, Axel R.
   7. Schnittger, Susanne

   2009 - Forschungsinformationssystem des UKE
9. Severe aplastic anaemia following leflunomide therapy.

   1. Wüsthof, Mirjam
   2. Smirnova, Anna
   3. Bacher, Ulrike
   4. Kröger, Nicolaus
   5. Zander, Axel R.
   6. Schuch, Gunter
   7. Bokemeyer, Carsten

   2009 - Forschungsinformationssystem des UKE
10. Outcome of allo-SCT for chronic myelomonocytic leukemia.

    1. Ocheni, Sunday
    2. Kröger, Nicolaus
    3. Zabelina, Tatjana
    4. Zander, Axel R.
    5. Bacher, Ulrike

    2009 - Forschungsinformationssystem des UKE
11. Pegfilgrastim compared to lenograstim after allogeneic peripheral blood stem-cell transplantation from unrelated donors.

    1. Ocheni, Sunday
    2. Zabelina, Tatjana
    3. Bacher, Ulrike
    4. Ayuketang Ayuk, Francis
    5. Zander, Axel R.
    6. Kröger, Nicolaus

    2009 - Forschungsinformationssystem des UKE
12. Second allogeneic stem cell transplantation in myeloid malignancies.

    1. Hartwig, Maite
    2. Ocheni, Sunday
    3. Asenova, Svetlana
    4. Wiedemann, Bettina
    5. Zabelina, Tatjana
    6. Ayuketang Ayuk, Francis
    7. Kabisch, Hartmut

    2009 - Forschungsinformationssystem des UKE
13. Second-generation tyrosine kinase inhibitors in the post-transplant period in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia.

    1. Klyuchnikov, Evgeny
    2. Schafhausen, Philippe
    3. Kröger, Nicolaus
    4. Brümmendorf, Tim
    5. Osanmaz, Okay
    6. Asenova, Svetlana
    7. Zabelina, Tatjana

    2009 - Forschungsinformationssystem des UKE
14. Quantitative monitoring of NPM1 mutations provides a valid minimal residual disease parameter following allogeneic stem cell transplantation.

    1. Bacher, Ulrike
    2. Badbaran, Anita
    3. Fehse, Boris
    4. Zabelina, Tatjana
    5. Zander, Axel R.
    6. Kröger, Nicolaus

    2009 - Forschungsinformationssystem des UKE
15. Interactive diagnostics in the indication to allogeneic SCT in AML.

    1. Bacher, Ulrike
    2. Haferlach, C
    3. Schnittger, S
    4. Kern, W
    5. Kröger, Nicolaus
    6. Zander, Axel R.
    7. Haferlach, T

    2009 - Forschungsinformationssystem des UKE
16. JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantation.

    1. Kröger, Nicolaus
    2. Alchalby, Haefaa
    3. Klyuchnikov, Evgeny
    4. Badbaran, Anita
    5. Hildebrandt, York
    6. Ayuketang Ayuk, Francis
    7. Bacher, Ulrike

    2009 - Forschungsinformationssystem des UKE
17. Monitoring of minimal residual disease in multiple myeloma after allo-SCT: flow cytometry vs PCR-based techniques.

    1. Lioznov, Michael
    2. Badbaran, A
    3. Fehse, Boris
    4. Bacher, Ulrike
    5. Zander, Axel R.
    6. Kröger, Nicolaus

    2008 - Forschungsinformationssystem des UKE
18. Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation.

    1. Ayuketang Ayuk, Francis
    2. Diyachenko, Galina
    3. Zabelina, Tatjana
    4. Wolschke, Christine
    5. Fehse, Boris
    6. Bacher, Ulrike
    7. Erttmann, Rudolf

    2008 - Forschungsinformationssystem des UKE
19. Allogeneic stem cell transplantation in acute myeloid leukemia: establishment of indications on the basis of individual risk stratification.

    1. Zander, Axel R.
    2. Bacher, Ulrike
    3. Finke, Jürgen

    2008 - Forschungsinformationssystem des UKE
20. Minimal residual disease diagnostics in myeloid malignancies in the post transplant period.

    1. Bacher, Ulrike
    2. Zander, Axel R.
    3. Haferlach, T
    4. Schnittger, S
    5. Fehse, Boris
    6. Kröger, Nicolaus

    2008 - Forschungsinformationssystem des UKE